Identification of a novel estrogen receptor-α variant and its upstream splicing regulator

Molecular Endocrinology

Volumn 24, Issue 5, 2010, Pages 914-922

  Ohshiro, Kazufumi ^a   Mudvari, Prakriti ^a   Meng, Qing Chang ^b,c   Rayala, Suresh K ^b,d   Sahin, Aysegul A ^b   Fuqua, Suzanne A W ^c   Kumar, Rakesh ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; COMPLEMENTARY DNA; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NUCLEAR PROTEIN; REGULATOR PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CATHEPSIN D; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, LIQUID; COS CELLS; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMUNOPRECIPITATION; MICE; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NUCLEAR PROTEINS; PROTEIN BINDING; RNA SPLICING; TANDEM MASS SPECTROMETRY; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77954850818     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0413     Document Type: Article

References (26)

1. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD 2003 Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144
2. Ashworth A 2004 Refocusing on BRCA1. Nat Cell Biol 6:916-917
3. Srebrow A, Kornblihtt AR 2006 The connection between splicing and cancer. J Cell Sci 119:2635-2641
4. Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S, Press MF 2001 Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res 61:3212-3219 (Pubitemid 32691978)
5. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC 1997 Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 272:27913-27918
6. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW 1999 Rhokinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 43:269-287
7. Bourguignon LY, Zhu H, Shao L, Chen YW 2001 CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 276:7327-7236
8. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD 1998 CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176:206-215
9. Stickeler E, Kittrell F, Medina D, Berget SM 1999 Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18:3574-3582
10. Leygue E, Huang A, Murphy LC, Watson PH 1996 Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res 56:4324-4327
11. Poola I, Speirs V 2001 Expression of alternatively spliced estrogen receptor α mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 78:459-4569
12. Koduri S, Goldhar AS, Vonderhaar BK 2006 Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3. Breast Cancer Res Treat 95:37-43
13. Lee LM, Cao J, Deng H, Chen P, Gatalica Z, Wang ZY 2008 ER-α36, a novel variant of ER-α, is expressed in ER-positive and -negative human breast carcinomas. Anticancer Res 28:479-483 (Pubitemid 351362856)
14. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF 2005 Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66. Biochem Biophys Res Commun 336:1023-1027
15. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF 2006 A variant of estrogen receptor-α, hER-α36: transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103:9063-9068
16. Penot G, Le Péron C, Mérot Y, Grimaud-Fanouillère E, Ferrière F, Boujrad N, Kah O, Saligaut C, Ducouret B, Métivier R, Flouriot G 2005 The human estrogen receptor-α isoform hERα46 antagonizes the proliferative influence of hERα66 in MCF7 breast cancer cells. Endocrinology 146:5474-5484
17. Hartmann AM, Stamm S 1997 Molecular cloning of a novel alternatively spliced nuclear protein. Biochim Biophys Acta 1353:224-230
18. Bourguignon LY 2001 CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia 6:287-297 (Pubitemid 33818529)
19. Screaton GR, Cáceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR 1995 Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14:4336-4349
20. Auboeuf D, Hönig A, Berget SM, O'Malley BW 2002 Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298:416-419
21. Qi C, Zhu YT, Chang J, Yeldandi AV, Rao MS, Zhu YJ 2005 Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2. Biochem Biophys Res Commun 328:393-398
22. Masuhiro Y, Mezaki Y, Sakari M, Takeyama K, Yoshida T, Inoue K, Yanagisawa J, Hanazawa S, O'malley BW, Kato S 2005 Splicing potentiation by growth factor signals via estrogen receptor phosphorylation. Proc Natl Acad Sci USA 102:8126-8131
23. Stevens TA, MeechR2006 BARX2 and estrogen receptor-α(ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion. Oncogene 25:5426-5435
24. Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S, Corbo L 2008 Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 31:212-221
25. Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R 2000 Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275:36238-36244
26. Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R 2007 Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Clin Cancer Res 13:4291-4429